Jake Duzsik of HEALTH: Niche Genre Success, Bad Omens Collab & Creative Persistence

Описание: On this episode of Artist Friendly, Joel Madden sits down with Jake Duzsik of HEALTH for a no-holds-barred talk about building a career in a niche genre, pushing creative boundaries, and staying relevant in a changing scene. With their latest album RAT WARS and a standout single with Bad Omens, HEALTH opens up about legacy, evolution and what it takes to keep moving forward.

What’s in the episode:
Jake on the making of RAT WARS — HEALTH’s sixth studio album and its heavy, chaotic vision.
Navigating the industrial/noise rock genre and what “success” looks like when you’re not following the mainstream.
The story behind their collaboration with Bad Omens and how cross-genre work can push boundaries.
Touring realities: opening for major acts, festival runs, and staying relevant while staying underground.
The evolution of HEALTH’s sound from early days to now — growth, risk and persistence.
Creative discipline when your audience is niche: writing, recording and staying true to the art.
Jake and Joel on how the music industry has shifted — streaming, genre walls, and audience expectations.
Mental and emotional resilience: facing burnout, staying inspired and redefining what “making it” means.
What’s next for HEALTH: new directions, collaborations, and surviving in the long game.

Watch full episodes for free on Veeps: https://veeps.com/artistfriendly

Stay connected and don’t miss a conversation:
Instagram: / artist.friendly
TikTok: / artist.friendly

About Artist Friendly:
On Artist Friendly, Good Charlotte’s Joel Madden gets real with today's breakthrough artists. From chart-toppers to rising stars, guests spill the untold stories behind their success: the pivotal moments, crushing failures, and insider moves that made all the difference. Drawing on his experience as an artist, performer and founder, Joel digs deeper than the surface. This isn't just interviews — it's a masterclass in creative survival from those who've lived it.